Quoin Pharmaceuticals Ltd Stock Market Value
| QNRX Stock | USD 0.30 0.01 3.45% |
| Symbol | Quoin |
Quoin Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quoin Pharmaceuticals. If investors know Quoin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quoin Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quoin Pharmaceuticals is measured differently than its book value, which is the value of Quoin that is recorded on the company's balance sheet. Investors also form their own opinion of Quoin Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Quoin Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quoin Pharmaceuticals' market value can be influenced by many factors that don't directly affect Quoin Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quoin Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quoin Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quoin Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Quoin Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Quoin Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Quoin Pharmaceuticals.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Quoin Pharmaceuticals on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Quoin Pharmaceuticals Ltd or generate 0.0% return on investment in Quoin Pharmaceuticals over 90 days. Quoin Pharmaceuticals is related to or competes with Revelation Biosciences, Virax Biolabs, Allarity Therapeutics, Biodexa Pharmaceticals, Unicycive Therapeutics, and Cardio Diagnostics. Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercia... More
Quoin Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Quoin Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Quoin Pharmaceuticals Ltd upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 57.78 | |||
| Value At Risk | (10.53) | |||
| Potential Upside | 14.29 |
Quoin Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Quoin Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Quoin Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Quoin Pharmaceuticals historical prices to predict the future Quoin Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.23) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | 1.83 |
Quoin Pharmaceuticals Backtested Returns
Quoin Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11 % return per unit of risk over the last 3 months. Quoin Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Quoin Pharmaceuticals' Variance of 64.8, risk adjusted performance of (0.12), and Coefficient Of Variation of (699.59) to confirm the risk estimate we provide. The company holds a Beta of -0.63, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Quoin Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Quoin Pharmaceuticals is likely to outperform the market. At this point, Quoin Pharmaceuticals has a negative expected return of -0.9%. Please make sure to check Quoin Pharmaceuticals' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Quoin Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.26 |
Poor predictability
Quoin Pharmaceuticals Ltd has poor predictability. Overlapping area represents the amount of predictability between Quoin Pharmaceuticals time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Quoin Pharmaceuticals price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Quoin Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Quoin Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Quoin Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Quoin Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Quoin Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Quoin Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Quoin Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Quoin Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Quoin Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Quoin Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Quoin Pharmaceuticals Lagged Returns
When evaluating Quoin Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Quoin Pharmaceuticals stock have on its future price. Quoin Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Quoin Pharmaceuticals autocorrelation shows the relationship between Quoin Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Quoin Pharmaceuticals Ltd.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.